Abstract
Pituitary tumors are discussed in some depth throughout this volume. This chapter will focus on a few ways in which pituitary tumors interact with the hypothalamic and diencephalic regions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Daughaday WH. Cushing’s disease and basophilic microadenomas. N Engl J Med 1984; 310:919–920.
Molitch ME: ACTH-secreting adenomas, in Post KP, Jackson IMD, Reichlin S (eds): Pituitary Adenoma. New York, Plenum Press, 1980, pp 119–140.
Schnall AM, Brodkey JS, Kaufman B, et al: Pituitary function after removal of pituitary microadenomas in Cushing’s disease. J Clin Endocrinol Metab 1978; 17: 410–417.
Boggan JE, Tyrell JB, Wilson CB: Transsphenoidal microsurgical management of Cushing’s disease. Report of 100 cases. J Neurosurg 1983; 59: 195–200.
Krieger DT, Amorosia L, Linich F: Cyproheptadine-induced remission of Cushing’s disease. N Engl J Med 1975; 293: 893–896.
Findling JW, Aron DC, Tyrell JB, et al: Selective venous sampling for ACTH in Cushing’s syndrome. Ann Intern Med 1981; 94: 647–652.
Oldfield EH, Chrousos GP, Schulte HM, et al: Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sampling. N Engl J Med 1985; 312: 100–103.
Hardy J: Cushing’s disease: 50 years later. Can J Neurol Sci 1980; 9: 375–380.
Lamberts SW, Uitterlinder P, Verschoor L, et al: Long-term treatment of acromegaly with somatostatin analogue SMS 201–995. N Engl J Med 1985; 313: 1576–1580.
Lindholm J, Riishede J, Vestergaard S, et al: No effect of bromocriptine in acromegaly: a controlled trial. N Engl J Med 1981; 304: 1450–1454.
Reichlin S, Molitch ME: Neuroendocrine aspects of pituitary adenomas. in Cammani F, Muller EE (eds): Pituitary Hyperfunction: Physiopathology and Clinical Aspects. New York, Raven Press, 1984, pp 47–70.
Molitch ME, Goodman RH, Post KD et al: Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/L-dopa. J Clin Endocrinol Metab 1982; 55: 1118–1123.
Vertosick FT: Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma. Neurosurgery 1985; 16: 261–266.
Goodman RH, Molitch ME, Post KD, et al: Prolactin secreting adenomas in the male, in Post KD, Jackson IMD, Reichlin S (eds): The Pituitary Adenoma. New York, Plenum Press, 1980, pp 91–108.
Landolt AM: Surgical treatment of pituitary prolactinomas: postoperative prolactin and fertility in seventy patients. Fertil Steril 1981; 35: 620–625.
Serri O, Somma M, Rasio E, et al: Prolactin secreting pituitary adenomas in males: transsphenoidal microsurgical treatment. Can Med Assoc J 1980; 122: 1007–1013.
McGregor AM, Scanlon MF, Hall K, et al: Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med 1979; 300: 291–293.
Thorner MO, Martin WH, Rogol AD, et al: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 1980; 51: 438–445.
Landolt AM, Minder H, Osterwalder V, et al: Bromocriptine reduces the size of cells in prolactinsecreting pituitary adenomas. Experientia 1983; 39: 625.
Tindall GT, Kovacs K, Horvath E, et al: Human prolactin-producing adenomas and bromocriptine: a histological immunocytochemical ultrastructural and morphometric study. J Clin Endocrinol Metab 1982; 55: 1178–1183.
Weiss MH, Wycoff RR, Yadley R, et al: Bromocriptine treatment of prolactin-secreting tumors: surgical implications. Neurosurgery 1983; 12: 640–642.
Thonier MO, Perryman RL, Rogol AD, et al: Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 1981; 53: 480–483.
Shucart WA: Implications of very high serum prolactin levels associated with pituitary tumors. J Neurosurg 1980; 52: 226–228.
Laws ER Jr, Kern EB: Pituitary tumors treated by transnasal microsurgery: 7 years of clinical experience with 539 patients, in Sano K, Takakura K, Fukushima T (eds): Functioning Pituitary Adenoma: Proceedings of the First Workshop on Pituitary Adenomas. Tokyo, 1980, pp. 25–34.
Serri O, Rasio E, Beauregard H, et al: Recurrence of hyperprolactinoma after selective transsphenoidal adenomectomy in women with prolactinomas. N Engl J Med 1983; 309: 280–283.
Rodman EF, Molitch ME, Post KD et al: Long-term follow-up of transsphenoidal selective adenomectomy for prolactinomas. JAMA 1984; 252: 921–924.
Vance ML, Evans WS, Thonier MO: Bromocriptine. Ann Intern Med 1984; 100: 78–91.
Krupp P, Turkalj I: Surveillance of Parlodel (bromocriptine) in pregnancy and offspring, in Jacobs HS, Harrison RF, Bonnar J, et al (eds): Prolactinomas and Pregnancy. Lancaster, England, MTP Press, 1983, pp 45–50.
Molitch ME, Elton RL, Blackwell RE: Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60: 698–705.
Luzzi A, Dallabonzana D, Oppizzi G: Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 1985; 313: 656–659.
Moriondo P, Travaglini P, Nissim M, et al: Bromocriptine treatment of microprolactinomas: Evidence of stable prolactin decrease after drug withdrawal. J Clin Endocrinol Metab 1985; 60: 764–772.
Molitch ME: Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985; 312: 1364–1370.
Gemzell C, Wang CF: Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363–372.
Konopka P, Taymond JP, Merceron RE, et al: Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983; 146: 935–938.
Maeda T, Ushiroyama T, Okuda K, et al: Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy. Obstet Gynecol 1983; 61: 117–121.
Gen M, Uozumi T, Ohta M, et al: Necrotic changes in prolactinomas after long term administration of bromocriptine. J Clin Endocrinol Metab 1984; 59: 463–470.
Landolt AM, Keller PJ, Froesch ER, et al: Bromocriptine: does it jeoparadize the result of later surgery for prolactinomas? Lancet 1982; 2: 657–658.
Landolt AM, Osterwalder V: Perivascular fibrosis in prolactinomas: is it increased by bromocriptine ? J Clin Endocrinol Metal, 1984; 58: 1179–1183.
Marcovitz S, Hardy J: Combined medical and surgical treatment of prolactin-producing pituitary tumors. Semin Reprod Endocrinol 1984; 2: 73–81.
Weiss MH: Medical and surgical management of function in pituitary tumors. Clin Neurosurg 1981; 28: 374–383.
Weiss MH, Teal J, Gott P, et al: Natural history of microprolactinomas: six year follow-up. Neurosurgery 1983; 12: 180–183.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Post, K.D. (1989). The Relationship between Pituitary Adenomas and the Diencephalon. In: Holtzman, R.N.N., Stein, B.M. (eds) Surgery of the Diencephalon. Contemporary Perspectives in Neurosurgery. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5586-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5586-1_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5588-5
Online ISBN: 978-1-4684-5586-1
eBook Packages: Springer Book Archive